EFFICACY OF INTRAOPERATIVE ARISTA POLYSACCHARIDE APPLICATION ON THE POSTOPERATIVE BLOOD LOSS IN PATIENTS UNDERGOING RARP FOR THE TREATMENT OF PROSTATE CANCER

This study tests whether applying a topical starch-based powder (Arista) during robotic-assisted prostate removal surgery reduces blood loss after the operation. It focuses on men with moderate erectile dysfunction who undergo nerve-sparing surgery. **You may be eligible if...** - You are between 45 and 68 years old - You have biopsy-confirmed prostate cancer being treated with robotic-assisted radical prostatectomy - You are having nerve-sparing surgery (unilateral or bilateral) - You were continent (no leaking urine) before surgery - Your erectile function score falls in the moderate to mild-to-moderate range (IIEF-5 score 8-16) **You may NOT be eligible if...** - You have high-risk prostate cancer (PSA 20 or above, Gleason score 8 or higher, or suspected spread) - You have suspected bone or organ metastases - You received hormone therapy before surgery - You have cognitive limitations preventing understanding of the study Talk to your doctor to see if this trial is right for you.